Peptic ulcers can develop when there is an imbalance between gastric acid secretion and gastroduodenal mucosal defense. Investigators are looking at the role of Helicobacter pylori in the development of peptic ulcer disease; eradication of the microorganism may reduce recurrence. Approved drug therapy includes H2-receptor antagonists, omeprazole, sucralfate, and antacids. Recommendations for treating and counseling patients are provided.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0160-3450(15)30757-1 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!